Grupo de investigación cardiovascular (GRINCAR): Envíos recentes
Mostrando ítems 71-75 de 233
-
Identification of an Elusive Spliceogenic MYBPC3 Variant in an Otherwise Genotype-Negative Hypertrophic Cardiomyopathy Pedigree
(Nature, 2022-05-04)[Abstract] The finding of a genotype-negative hypertrophic cardiomyopathy (HCM) pedigree with several affected members indicating a familial origin of the disease has driven this study to discover causative gene variants. ... -
Severe Heart Failure in the Setting of Inflammatory Cardiomyopathy With Likely Pathogenic Titin Variant
(Elsevier, 2022-04)No abstract available -
Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation: the FANTASIIA study
(Elsevier, 2019-05-31)[Abstract] Introduction and objectives: To compare the long-term results of direct oral anticoagulants (DOAC) vs vitamin K antagonists (VKA) in real-world-patients with nonvalvular atrial fibrillation (NVAF) in a nationwide, ... -
Systemic treatment of immune-mediated keratoconjunctivitis sicca with allogeneic stem cells improves the schirmer tear test score in a canine spontaneous model of disease
(MDPI, 2021-12-20)[Abstract] Keratoconjunctivitis sicca (KCS) is characterized by ocular discomfort, conjunctival hyperaemia, and corneal scarring, causing reduced aqueous tear production that can be measured using the standard Schirmer ... -
Relationship between multimorbidity and outcomes in atrial fibrillation
(Elsevier, 2021-07-23)[Abstract] Background: Multimorbidity is common in atrial fibrillation (AF) patients. Charlson comorbidity index (CCI) is used to evaluate multimorbidity in the general population. Limited long-term data are available on ...